12:00 AM
Jul 21, 2014
 |  BC Week In Review  |  Clinical News  |  Clinical Status

XEN-D0501: Phase IIa started

Ario began a double-blind, placebo-controlled, crossover, U.K. Phase IIa trial to evaluate oral XEN-D0501 in about 20 patients with chronic idiopathic cough. XEN-D0501 is also in...

Read the full 110 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >